IBM, WellPoint and Memorial Sloan-Kettering Cancer Center have announced what they say are the first commercially developed applications based on IBM's Watson technology. They include an advanced clinical decision support system for oncologists, and tools designed to accelerate and streamline the prior authorization process at healthplans.

For more than a year, IBM has partnered separately with WellPoint and Memorial Sloan-Kettering to train Watson in the areas of oncology and utilization management. During this time, clinicians and technology experts spent thousands of hours "teaching" Watson how to process, analyze and interpret the meaning of complex clinical information, using natural language processing. Read full story on InformationWeek


Post a comment to the original version of this story on InformationWeek